24/7 Patient Assistance: 760-405-8205

Wayne Harris, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Wayne Harris is a medical oncologist from Atlanta, Georgia and he works at several hospitals in the area, such as Atlanta Veterans Affairs Medical Center and Emory University Hospital. He got his diploma from Loma Linda University School of Medicine and did his residency years in Internal Medicine at the renowned Emory University and a fellowship in Hematology/Oncology at the same university. The doctor is certified in Medical Oncology and has an experience of more than 20 years.

  • Education & Training


    Loma Linda University School of Medicine

    Medical School


    Emory University



    Emory University


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Atlanta VA Medical Center

    Languages: English/Spanish

    (404) 321–6111

    1670 Clairmont Road

    Decatur, Georgia 30033-4004

    Read More

    Emory University Hospital

    Languages: English/Spanish

    (404) 712–2000

    1364 Clifton Road NE

    Atlanta, Georgia 30322-1102

    Read More

    Emory University Hospital Midtown

    Languages: English/Spanish

    (404) 686–4411

    550 Peachtree Street NE

    Atlanta, Georgia 30308-2247

    Read More

    Grady Memorial Hospital

    Languages: English/Spanish

    (404) 616-1000

    80 Jesse Hill Jr Dr SE

    Atlanta, Georgia 30303

    Read More
  • Publications & Memberships

    Dr. Wayne Harris has contributed to 3 publications.

    Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.

    Guo, X.,Koff, J. L.,Moffitt, A. B.,Cinar, M.,Ramachandiran, S.,Chen, Z.,Switchenko, J. M.,Mosunjac, M.,Neill, S. G.,Mann, K. P.,Bagirov, M.,Du, Y.,Natkunam, Y.,Khoury,...; Oncogene. 2017 Apr 04.

    See more >>

    Biomarkers for evaluating racial disparities in clinical outcome in patients with renal cell carcinoma.

    Harris, W. B.; Mol. Aspects Med.. 2015 Jun 15.

    See more >>

    Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model.

    Sahin, K.,Cross, B.,Sahin, N.,Ciccone, K.,Suleiman, S.,Osunkoya, A. O.,Master, V.,Harris, W.,Carthon, B.,Mohammad, R.,Bilir, B.,Wertz, K.,Moreno, C. S.,Walker, C. L.,K...; Arch. Biochem. Biophys.. 2015 Jan 21.

    See more >>